No disease recurrences after short course of neoadjuvant immunotherapy, according to follow-up

A short course of neoadjuvant immunotherapy continues to show long-term outcomes in patients with locally advanced mismatch repair–deficient (dMMR) co…

Continue in Briflio to read, react, comment, and share.